Aurinia Pharmaceuticals
AUPH
$5.10
Share price
-1.35%
Change (1 day)
-55.96%
Change (1 year)
Categories
Revenue for Aurinia Pharmaceuticals (AUPH)
Revenue in 2023 (TTM): $0.17 B
According to Aurinia Pharmaceuticals
's latest financial reports the company's current revenue (TTM
) is $0.17 B.
In 2022 the company made a revenue of $0.13 B an increase over the years 2021 revenue that were of $45.6 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Aurinia Pharmaceuticals from 2002 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.17 B | 30.95% |
| 2022 | $0.13 B | 193.89% |
| 2021 | $45.6 M | -9% |
| 2020 | $50.11 M | 15660.38% |
| 2019 | $0.31 M | -31.32% |
| 2018 | $0.46 M | 10.5% |
| 2017 | $0.41 M | 142.2% |
| 2016 | $0.17 M | -26.38% |
| 2015 | $0.23 M | -15.47% |
| 2014 | $0.27 M | -70.73% |
| 2013 | $0.94 M | -84.37% |
| 2012 | $6.07 M | 542.57% |
| 2011 | $0.94 M | -72.25% |
| 2010 | $3.4 M | 23.94% |
| 2009 | $2.74 M | -29.76% |
| 2008 | $3.91 M | 77.45% |
| 2007 | $2.2 M | -36.32% |
| 2006 | $3.46 M | -1098.72% |
| 2005 | -$0.35 M | -127.96% |
| 2004 | $1.24 M | -83.82% |
| 2003 | $7.66 M | -36.88% |
| 2002 | $12.14 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $13.11 B | 7,373.63% | 🇺🇸 USA |
 Pieris Pharmaceuticals PIRS | $47.35 M | -73.02% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | $4.49 M | -97.44% | 🇺🇸 USA |